首页> 外文期刊>Acta Poloniae Pharmaceutica: Durg Research >Clarithromycin targeting to lung: optimization of the size, morphology and release characteristics of albumin microspheres.
【24h】

Clarithromycin targeting to lung: optimization of the size, morphology and release characteristics of albumin microspheres.

机译:克拉霉素靶向肺:优化白蛋白微球的大小,形态和释放特性。

获取原文
获取原文并翻译 | 示例
           

摘要

Micropheres are drug carrier system which ensures controlled release in the shape of solid sphere particles with variable diameter distributions from a few microns to a milimeter of size. The active substance is dispersed in molecular level or in forms of macroscopic particles. Clarithromycin was selected as the model active substance in our study. Clarithromycin microspheres were prepared and evaluated by an emulsion polymerization technique. Two matrix materials have been considered as the basis in preparing the selected model active substance. Natural human serum albumin and bovine serum albumin, which were frequently used in early microsphere studies and are being used in some studies as microshpere matrix material were used. Albumin microspheres containing clarithromycin were prepared by heat stabilization at different stirring rate. In the first part of our study, drug content, payload, particle size, surface morphology and release characteristics from microspheres prepared.
机译:微球是药物载体系统,可确保以几微米到一毫米大小的可变直径分布,以固体球形颗粒的形式控制释放。活性物质以分子水平或宏观颗粒形式分散。在我们的研究中选择克拉霉素作为模型活性物质。制备克拉霉素微球并通过乳液聚合技术进行评估。已经考虑了两种基质材料作为制备所选模型活性物质的基础。天然人血清白蛋白和牛血清白蛋白,它们经常用于早期微球研究中,并在某些研究中用作微shpere基质材料。通过在不同的搅拌速率下热稳定来制备含有克拉霉素的白蛋白微球。在我们的研究的第一部分中,准备了药物含量,有效载荷,粒径,表面形态和微球的释放特性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号